Plasma interleukin-18 levels in chronic renal failure and continuous ambulatory peritoneal dialysis

Blood Purif. 2005;23(2):144-8. doi: 10.1159/000083620. Epub 2005 Jan 25.

Abstract

Background/aims: Based on associations of interleukin (IL)-18 with chronic inflammation, we investigated IL-18, IL-6, and tumor necrosis factor-alpha (TNF-alpha) in patients with chronic renal failure (CRF) and patients undergoing continuous ambulatory peritoneal dialysis (CAPD).

Methods: Plasma was evaluated by ELISA methodology in 15 healthy controls, 27 CRF and 15 CAPD patients.

Results: Plasma IL-18 levels in CRF (572.5 +/- 41.9 pg/ml) or CAPD (479.2 +/- 47.4 pg/ml) were significantly higher than normal (263.6 +/- 20.0 pg/ml), but there was no difference in IL-18 between CRF and CAPD patients. The IL-18 concentration negatively correlated with creatinine clearance (Ccr). However, the duration of dialysis, normalized protein nitrogen appearance, weekly Ccr, and Kt/V(urea) were not correlated with plasma IL-18 in CAPD. The plasma IL-18 concentration was positively correlated with TNF-alpha but not with IL-6 in renal failure patients with or without CAPD.

Conclusion: Uremia is the principal origin of increased plasma IL-18 in these patients. Increased IL-18 levels may be associated with Th1 differentiation and elevated TNF-alpha.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / blood
  • Case-Control Studies
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Inflammation / diagnosis
  • Interleukin-18 / blood*
  • Interleukin-6 / blood
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / therapy*
  • Middle Aged
  • Peritoneal Dialysis, Continuous Ambulatory / adverse effects*
  • Tumor Necrosis Factor-alpha / analysis
  • Uremia / immunology

Substances

  • Biomarkers
  • Interleukin-18
  • Interleukin-6
  • Tumor Necrosis Factor-alpha